Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone De Leo

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Molecular and Cellular Endocrinology|December 3, 2014
Telomerase in differentiated thyroid cancer: promoter mutations, expression and localizationMarina Muzza, Carla Colombo, Stefania Rossi, et al.
Blood|January 21, 2012
Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cellsGiovanni Reddiconto, Claudia Toto, Ilaria Palamà, et al.
Journal of Endocrinological Investigation|April 4, 2018
Correction to: Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancerAlberto S Tresoldi, Laura F Sburlati, Marcello Rodari, et al.
Journal of Endocrinological Investigation|May 22, 2014
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancerAlberto S Tresoldi, Laura F Sburlati, Marcello Rodari, et al.
Thyroid : Official Journal of the American Thyroid Association|December 4, 2018
Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission ProbabilityCarla Colombo, Marina Muzza, Maria Carla Proverbio, et al.
The Journal of Clinical Endocrinology and Metabolism|February 21, 2014
Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safetyCaterina Mian, Michela Perrino, Carla Colombo, et al.
European Thyroid Journal|April 8, 2025
Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study)Giulia Puliani, Marta Bianchini, Carlotta Giani, et al.
Thyroid : Official Journal of the American Thyroid Association|July 30, 2025
Clinical and Pathological Factors Associated with Disease Persistence in Pediatric Patients with Differentiated Thyroid CarcinomaSimone De Leo, Valeria Bottici, Gabriella Pellegriti, et al.
Thyroid : Official Journal of the American Thyroid Association|September 19, 2023
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune ThyroiditisSimone De Leo, Silvia D'Elia, Giorgio Grani, et al.
The Journal of Clinical Endocrinology and Metabolism|August 16, 2024
Data-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk Thyroid Cancer Follow-up: ITCO Real-world AnalysisGiorgio Grani, Silvia D'Elia, Efisio Puxeddu, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Molecular and Cellular Endocrinology|December 3, 2014
Telomerase in differentiated thyroid cancer: promoter mutations, expression and localizationMarina Muzza, Carla Colombo, Stefania Rossi, et al.
Blood|January 21, 2012
Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cellsGiovanni Reddiconto, Claudia Toto, Ilaria Palamà, et al.
Journal of Endocrinological Investigation|April 4, 2018
Correction to: Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancerAlberto S Tresoldi, Laura F Sburlati, Marcello Rodari, et al.
Journal of Endocrinological Investigation|May 22, 2014
Radioiodine ablation with 1,850 MBq in association with rhTSH in patients with differentiated thyroid cancerAlberto S Tresoldi, Laura F Sburlati, Marcello Rodari, et al.
Thyroid : Official Journal of the American Thyroid Association|December 4, 2018
Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission ProbabilityCarla Colombo, Marina Muzza, Maria Carla Proverbio, et al.
The Journal of Clinical Endocrinology and Metabolism|February 21, 2014
Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safetyCaterina Mian, Michela Perrino, Carla Colombo, et al.
European Thyroid Journal|April 8, 2025
Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study)Giulia Puliani, Marta Bianchini, Carlotta Giani, et al.
Thyroid : Official Journal of the American Thyroid Association|July 30, 2025
Clinical and Pathological Factors Associated with Disease Persistence in Pediatric Patients with Differentiated Thyroid CarcinomaSimone De Leo, Valeria Bottici, Gabriella Pellegriti, et al.
Thyroid : Official Journal of the American Thyroid Association|September 19, 2023
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune ThyroiditisSimone De Leo, Silvia D'Elia, Giorgio Grani, et al.
The Journal of Clinical Endocrinology and Metabolism|August 16, 2024
Data-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk Thyroid Cancer Follow-up: ITCO Real-world AnalysisGiorgio Grani, Silvia D'Elia, Efisio Puxeddu, et al.
Pageof 6